Vilya | Menlo Ventures
Vilya is a computational biotechnology company creating a novel class of medicines to treat disease targets inside of cells using AI.| Menlo Ventures
Vilya is a computational biotechnology company creating a novel class of medicines to treat disease targets inside of cells using AI.| Menlo Ventures
Recursion is discovering transformative new treatments by combining automation, machine learning, and the world’s largest biological image datasets.| Menlo Ventures
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.| Menlo Ventures
Anthropic is an AI safety and research company that builds reliable, interpretable, and steerable AI systems.| Menlo Ventures
The Anthology Fund is a $100 million initiative between Menlo Ventures and Anthropic to fund world-changing AI companies.| Menlo Ventures
